Cell and Gene Outsourcing

  1. Contract Manufacturing Outsourcing Trends For Advanced Therapies In 2025 And Beyond 9/4/2025

    Contract manufacturing continues to emerge as the widely adopted model for bringing cell therapies, gene therapies, RNA therapeutics, and oligonucleotides to patients worldwide.

  2. Generation Of A Universal AAV Packaging Cell Line For Commercial Gene Therapy Manufacturing 9/4/2025

    Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.

  3. Development Of A Serotype-Agnostic AAV Platform For Suspension Cell Culture 9/4/2025

    To evaluate performance, we compared a suspension process with an adherent iCELLis (200 m²) system, assessing upstream and downstream recovery, as well as analytics using an AAV testing platform.

  4. Pioneering Affordable CAR-T Cell Therapies In India 9/3/2025

    CAR-T cell therapy is poised to transform cancer care in India, with new initiatives aiming to make this breakthrough treatment both clinically feasible and financially accessible.

  5. Cell Therapies In The Treatment Of Autoimmune Diseases 9/3/2025

    Uncover how cell therapies are unlocking new possibilities for autoimmune disease treatments by overcoming barriers from self-antigen recognition to complex inflammatory microenvironments.

  6. Patient Selection By Anti-AAV Total Antibody Binding 9/3/2025

    Advance the future of medicine by harnessing AAV-based gene therapies — powerful delivery systems that drive safer, more effective, and potentially curative treatments for genetic disorders.

  7. Unlocking The Power Of Spectral Flow 9/3/2025

    Unlock deeper insights into the immune system with spectral flow cytometry — a powerful tool to drive cell therapy development, optimize treatments, and improve patient outcomes.

  8. Non-Viral Delivery Of Complex Cargos For Large-Scale T-Cell Manufacturing 9/1/2025

    We operate at the forefront of emerging technologies – cell and gene, microbial, mRNA – to help pioneer our customers’ breakthrough medicines. Explore a next-generation large-scale electroporation platform.

  9. Automating Cell Therapy Manufacturing And Enabling Rapid Multi-Site Tech Transfer 8/27/2025

    Find out how automating cell therapy manufacturing with a flexible platform can improve biological performance, streamline tech transfer, and support regulatory confidence for scalable, multi-site production.

  10. Enabling CTA Submission In Record Time: Adenovirus Program Success 8/25/2025

    What does it take to bring an adenovirus-based therapy to the clinic – faster and without compromising quality? Find actionable insights to help improve efficiency and accelerate development timelines.